• John Larrimer

OSHA Cites New England Facility for Needle Biohazard Violations

New England Hematology/Oncology Associates PC, a medical service provider, is facing federal fines for workplace safety violations, according to Boston.com. The US Department of Labor’s Occupational Safety and Health Administration (OSHA) investigated the facility after it received reports of workers being exposed to biohazards.

New England Hematology/Oncology PC has denied the allegations and has filed an appeal with OSHA. OSHA inspected the facility in April and issued citations for putting workers at risk by exposing them to contaminated needles. Proposed fines total $46,900.

“We have not seen the press release so all I can say is that we completely disagree with the citations that were issued and their classifications [as willful and serious],” said Amy Carlton, administrative director of New England Hematology/Oncology Associates PC.

These are serious violations, and OSHA does not issue them without merit. The OSHA reports indicate that employees voiced concerns over the needles to management, who failed to rectify the situation.

Please visit our website for information on workers comp, and contact our firm for a free consultation.

Larrimer & Larrimer, LLC—Columbus workers comp attorneys.

#WorkersComp

0 views0 comments

Recent Posts

See All

Returning to Work After Injury

Should I return to work light duty? If you are hurt on the job, your doctor may give you work restrictions. If those restrictions prevent you from returning to your normal duties, you may be entitled

How do I get paid after an Injury?

Workplace injuries can set you back Work injuries don’t just hurt physically, they often have a lasting financial impact. If you are hurt at work and the injury prevents you from returning to full dut

Hurt at work? What now?

When You Get Hurt on the Job If you suffer a workplace injury, it is important to notify your employer of the injury and seek treatment as soon as possible. While your injuries may resolve over time